Classes
DEA Class; Rx
Common Brand Names; Ocupress (DSC)
- Antiglaucoma, Beta-Blockers
Description
Long-acting, nonselective, beta-blocker; oral product used for HTN; ophthalmic product indicated for open-angle glaucoma or ocular hypertension; low lipid solubility; moderate intrinsic sympathomimetic activity (ISA).
Indications
Indicated for the treatment of chronic open-angle glaucoma and ocular hypertension either alone or in combination with other intraocular pressure lowering agents.
Contraindications
Asthma, uncompensated CHF, any beta-blocker side effects, hypersensitivity, severe COPD, 2°/3° AV block, cardiogenic shock
Adverse Effects
- Burning sensation in eye (25%)
- Conjunctival hyperemia (25%)
- Excessive tear production (25%)
- Eye irritation (25%)
- Blurred and cloudy vision
- Photophobia
- Decreased night vision
- Ptosis
- Ocular signs including blepharoconjunctivitis, abnormal corneal staining, and corneal sensitivity occurred occasionally
- Systemic side effects may be similar to systemic beta-blockers (bradycardia, aggravation of CHF, asthma, caution in diabetes as may mask signs of hypolgycemia, nightmares, impotence, tiredness, etc)
- Reduction of systemic side effects by putting finger in corner of eye (occluding punctum) or by gentle eyelid closure (without opening & closing lid) for 3 min
Pregnancy and Lactation
Pregnancy Category: C
Lactation: excretion in milk unknown; use with caution
Maximum Dosage
2 drops/day 1% carteolol ophthalmic solution in the affected eye(s).
2 drops/day 1% carteolol ophthalmic solution in the affected eye(s).
Safety and efficacy have not been established.
Safety and efficacy have not been established.
How supplied
Carteolol hydrochloride
ophthalmic solution
- 1%
